v3.25.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Operating activities    
Net income $ 3,180 $ 3,160
Adjustments to reconcile net income to net cash provided by/(used in) operating activities:    
Depreciation and amortization 411 219
Noncash lease expense 69 64
Stock-based compensation 467 355
Deferred income tax expense (benefit) (78) (80)
Contingent consideration fair value adjustments 172 (6)
Other investment (gains) (433) (59)
Net (gains) losses within CIPs (183) (170)
Net (purchases) proceeds within CIPs (1,984) (1,452)
(Earnings) losses from equity method investees (93) (92)
Distributions of earnings from equity method investees 147 26
Changes in operating assets and liabilities:    
Accounts receivable 114 (100)
Investments, trading 78 (40)
Other assets (2,480) (1,064)
Accrued compensation and benefits (1,186) (948)
Accounts payable and accrued liabilities 182 96
Other liabilities 1,853 1,048
Net cash provided by/(used in) operating activities 236 957
Investing activities    
Purchases of investments (434) (517)
Proceeds from sales and maturities of investments 230 520
Distributions of capital from equity method investees 262 317
Net consolidations (deconsolidations) of sponsored investment funds (68) (34)
Acquisition, net of cash acquired (3,106) (74)
Purchases of property and equipment (167) (71)
Net cash provided by/(used in) investing activities (3,283) 141
Financing activities    
Repayments of long-term borrowings (796) (1,000)
Proceeds from long-term borrowings 1,080 2,979
Cash dividends paid (1,646) (1,553)
Proceeds from stock options exercised 98 163
Repurchases of common stock (1,053) (1,153)
Net proceeds from (repayments of) borrowings by CIPs (29) 72
Net subscriptions received/(redemptions/distributions paid) from noncontrolling interest holders 1,716 955
Other financing activities (5) (9)
Net cash provided by/(used in) financing activities (635) 454
Effect of exchange rate changes on cash, cash equivalents and restricted cash 398 (60)
Net increase/(decrease) in cash, cash equivalents and restricted cash (3,284) 1,492
Cash, cash equivalents and restricted cash, beginning of period 12,779 8,753
Cash, cash equivalents and restricted cash, end of period 9,495 10,245
Supplemental schedule of noncash investing and financing transactions:    
Issuance of common stock 42 417
Increase (decrease) in noncontrolling interests due to net consolidation (deconsolidation) of sponsored investment funds $ (1,192) $ (803)